GlassScriptPhysician profile
Robert Mc Swain
NPI 1508868985
$7,833.59
in general payments reported to CMS, 2019-2025
25 companies · $1,250 in 2025
The $1,250 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,701 · 2020: $933 · 2021: $198 · 2022: $1,647 · 2023: $384 · 2024: $720 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,181 · Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,181.31 |
| Food and Beverage | $1,173.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,080.27 | 2019-2020 | |
| Philips North America LLC | $1,682.17 | 2021-2022 | |
| Abbott Laboratories | $1,463.84 | 2024-2025 | Aveir |
| Boston Scientific Corporation | $402.39 | 2019-2025 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $200.21 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $163.12 | 2019-2024 | Xarelto |
| Pfizer INC. | $141.75 | 2019-2025 | |
| Medtronic, INC. | $128.32 | 2021-2022 | |
| Amgen INC. | $122.93 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.60 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $64.31 | 2023-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $43.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.13 | 2024 | |
| Amarin Pharma, INC. | $27.71 | 2019 | |
| Novo Nordisk INC | $26.79 | 2025 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $26.41 | 2019-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.13 | 2019 | |
| Vital Connect, INC | $21.48 | 2023 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $19.51 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $19.35 | 2020 | |
| Esperion Therapeutics, INC. | $19.02 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $16.57 | 2023 | |
| Aegerion Pharmaceuticals, INC. | $12.97 | 2019 | |
| Becton, Dickinson and Company | $10.97 | 2019 | |
| Cardiovascular Systems INC. | $3.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mc Swain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.